CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishBackground: Long-acting β2 agonists (LABAs) are effective second-line bronchodilator controller agents in asthma, although they may also increase the risk of hospitalization and asthma-related death in certain situations. Despite the interesting findings obtained with short-acting β2 agonists (SABAs), negative studies are available with LABAs in the treatment of allergic rhinitis. This is quite surprising given that there is now clear documentation of the link between asthma and allergic rhinitis. Objective: The aim of this review is to examine the role of β 2 agonists in patients with asthma who also suffer from allergic rhinitis and to try to explain the differences observed between SABAs and LABAs in rhinitis. Methods: SCOPUS, GOOGLE SCHOLAR and MEDLINE were searched for abstracts and papers; the search was completed in March 2008. No restriction was placed on language. Conclusion: The intriguing united airway concept led to the hypothesis that common therapies may influence both and asthma and allergic rhinitis. Consequently, better designed studies with LABAs in allergic rhinitis are now mandatory. In particular, further studies are necessary to investigate clinically relevant anti-inflammatory synergy between inhaled corticosteroids and LABAs in upper airways. It will also be interesting to assess whether ultra-LABAs (once-daily LABAs) are active in allergic rhinitis, although the information we have seems to exclude a role for these agents. © 2008 Informa UK Ltd.
Matera M.G., C.G. (2008). Long-acting ß2 agonists in asthma and allergic rhinitis. EXPERT OPINION ON PHARMACOTHERAPY, 9(9), 1531-1539.
| Tipologia: | Articolo su rivista | |
| Citazione: | Matera M.G., C.G. (2008). Long-acting ß2 agonists in asthma and allergic rhinitis. EXPERT OPINION ON PHARMACOTHERAPY, 9(9), 1531-1539. | |
| IF: | Con Impact Factor ISI | |
| Lingua: | English | |
| Settore Scientifico Disciplinare: | Settore MED/10 - Malattie dell'Apparato Respiratorio | |
| Revisione (peer review): | Sì, ma tipo non specificato | |
| Tipo: | Articolo | |
| Rilevanza: | Rilevanza internazionale | |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1517/14656566.9.9.1531 | |
| Stato di pubblicazione: | Pubblicato | |
| Data di pubblicazione: | 2008 | |
| Titolo: | Long-acting ß2 agonists in asthma and allergic rhinitis | |
| Autori: | ||
| Autori: | Matera M.G., Curradi G., Cazzola M. | |
| Appare nelle tipologie: | 01 - Articolo su rivista |
File in questo prodotto:
http://hdl.handle.net/2108/42168
Copyright © 2021